Genfit S.A. (LON:0QT6)

CTI BioPharma Revenue

In the year 2024, Genfit had annual revenue of 70.69M EUR with 105.01% growth. Genfit had revenue of 9.59M in the half year ending December 31, 2024, a decrease of -32.01%.

• Revenue: 70.69M EUR
• Revenue Growth: +105.01%
• P/S Ratio: 2.46
• Revenue / Employee: 392.73K EUR
• Employees: 180
• Market Cap: 143.75M USD

Revenue Chart

* This company reports financials in EUR.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	70.69M	36.21M	105.01%
Dec 31, 2023	34.48M	8.24M	31.38%
Dec 31, 2022	26.25M	-59.11M	-69.25%
Dec 31, 2021	85.36M	76.67M	883.14%
Dec 31, 2020	8.68M	-30.29M	-77.72%